International Strategies for Tropical Disease Treatments - Experiences with Praziquantel - EDM Research Series No. 026
(1998; 113 pages) Voir le document au format PDF
Table des matières
Afficher le documentAbstract
Afficher le documentAcknowledgments
Afficher le documentInformation on authors
Afficher le documentExchange rates used in the report
Ouvrir ce répertoire et afficher son contenuChapter 1: Policies for praziquantel*
Ouvrir ce répertoire et afficher son contenuChapter 2: Bayer & E. Merck: Discovery and development of praziquantel*
Ouvrir ce répertoire et afficher son contenuChapter 3: Shin Poong Pharmaceutical Co.: Process development in the Republic of Korea*
Ouvrir ce répertoire et afficher son contenuChapter 4: The Egyptian International Pharmaceutical Industries Co.: Praziquantel formulation*
Ouvrir ce répertoire et afficher son contenuChapter 5: The international supply of praziquantel*
Ouvrir ce répertoire et afficher son contenuChapter 6: Demand for praziquantel and national distribution*
Ouvrir ce répertoire et afficher son contenuChapter 7: Prices and production costs of praziquantel*
Afficher le documentOther documents in the DAP Research Series
Afficher le documentDAP Research Series No. 26
 

Information on authors

Agnes Brinkmann, MD, is Consultant with Deutsche Gesellschaft für Technische Zusammenarbeit (GTZ) GmbH, Germany.

Karin Dumbaugh, DSc, is Executive Director of the Harvard International Health Leadership Forum at the Harvard School of Public Health.

Sameh G. El-Saharty, MD, MPH, is Senior Programme Management Specialist, Health and Population, at the US Agency for International Development, Cairo.

Ramesh Govindaraj, MBBS, MS, is a doctoral candidate in the Department of Population and International Health at the Harvard School of Public Health.

Christopher Mast, MS, is a doctoral candidate at the School of Public Health, Johns Hopkins University.

John A. Norris, MBA, JD, is Adjunct Lecturer on Health Law at the Harvard School of Public Health.

Michael R. Reich, PhD, is Takemi Professor of International Health Policy at the Harvard School of Public Health.

Bong-min Yang, PhD, is Professor of Economics at the School of Public Health, Seoul National University, Republic of Korea.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013